Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: health (care OR case) costs
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
Showing
1
-
19
of
19
Search:
'health (care OR case) costs'
,
query time: 0.10s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Sucroferric oxyhydroxide (Velphoro -- Vifor Fresenius Medical
Care
Renal Pharma Ltd.)...
Published 2019
CADTH
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Sucroferric oxyhydroxide (Velphoro -- Vifor Fresenius Medical
Care
Renal Pharma Ltd.)...
Published 2019
CADTH
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
7
CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
8
CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Daclizumab (Zinbryta -- Biogen Canada Inc.) : indication: relapsing-remitting multiple sclerosis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Cost
-Benefit Analysis...
”
Read Now
10
CADTH Canadian drug expert committee recommendation: Cysteamine ophthalmic solution (Cystadrops -- recordati rare diseases Canada Inc.) : indication : treatment of corneal cystine...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
11
CADTH Canadian drug expert committee recommendation: Cysteamine ophthalmic solution (Cystadrops -- recordati rare diseases Canada Inc.) : indication : treatment of corneal cystine...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Subjects:
“
...Insurance,
Health
, Reimbursement...
”
Read Now
15
Optimal use of minimally invasive glaucoma surgery: Recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Cost
-Benefit Analysis...
”
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
Subjects:
“
...
Cost
-Benefit Analysis...
”
Read Now
17
Optimal use of minimally invasive glaucoma surgery: Recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... and procedures for adults with glaucoma? Should MIGS devices and procedures be funded by the public
health
care
...
”
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
“
... must be under the
care
of a practitioner experienced in the
care
of patients with HIV. The
cost
of DTG...
”
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
“
... without an NS5A inhibitor, if the following conditions are met. The patient is under the
care
of a...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
17
330 - Economics
9
800 - Literature & rhetoric
2
140 - Specific philosophical schools
1
700 - The arts; fine & decorative arts
1
Language
English
19
Collection
National Center for Biotechnology Information
19
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
15
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&lookfor=health+%28care+OR+case%29+costs&type=AllFields
Send by Email
×
Loading...